OLD Category: signatures

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

• Li R, He Y, Zhang H, Wang J, Liu X, Liu H, Wu H, Liang Z

Immune cell profiling in atherosclerosis: role in research and precision medicine

• Fernandez DM, Giannarelli C

Two-miRNA–based finger-stick assay for estimation of absorbed ionizing radiation dose

• Yadav M, Bhayana S, Liu J...Xu-Welliver M, Chakravarti A, Jacob NK

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort

• Weyerer V, Stoehr R, Bertz S...Wullich B, Hartmann A, Eckstein M

Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers

• Jang GF, Crabb JS, Hu B, Willard B, Kalirai H, Singh AD, Coupland SE, Crabb JW

Progress in molecular feature of smoldering mantle cell lymphoma

• Jiang P, Desai A, Ye H

Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

• Angerilli V, Fontana E, Lonardi S...Loupakis F, Valeri N, Fassan M

Systematic review of the immunological landscape of Wilms tumors

• Palmisani F, Kovar H, Kager L, Amann G, Metzelder M, Bergmann M

Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine

• Russick J, Foy PE, Josseaume N...Dragon-Durey MA, Pagès F, Cremer I

Circulating HMGB1 is elevated in veterans with Gulf War Illness and triggers the persistent pro-inflammatory microglia phenotype in male C57Bl/6J mice

• Garza-Lombó C, Thang M, Greve HJ, Mumaw CL, Messenger EJ, Ahmed C, Quinn E, Sullivan K, Block ML

Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation

• Rabbani N, Xue M, Weickert MO, Thornalley PJ

Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells

• Wan Mohd Tajuddin WNB, Abas F, Othman I, Naidu R